QuantumSphere Unveils Pure Magnetic Nanopowder for Biomedical and Magnetic Resonance Imaging (MRI) Applications

QuantumSphere has unveiled the first pure magnetic nanopowder for biomedical applications. QuantumSphere produces, manufactures and sells magnetic nanopowder based on a material that is not harmful to the body.

QuantumSphere’s magnetic nanopowder will be used to dramatically enhance Magnetic Resonance Imaging (MRI) applications. MRI technology can be leveraged in conjunction with QuantumSphere’s magnetic nanoparticles to focus electromagnetic energy waves into the body to view internal organs better, such as the liver, to see damage, or investigate the functions of internal organs. QuantumSphere’s magnetic nanopowders offer orders-of-magnitude performance improvements when compared to existing imaging materials, such as gadolinium dies, and other standard materials used today. Entities such as General Electric, Walter Reed Army Medical Center, and leading academic institutions such as the Mayo Clinic can significantly benefit from this advance.

"QuantumSphere’s metallic nanopowders enable users to leverage cutting-edge technology that vastly improves the understanding of disease and organ function. The use of our product will ignite awareness and advances in the MRI field as our nanopowders offer a breakthrough technology that will drive new discoveries and patient analysis. Although the MRI field is a multi-billion market, MRIs use materials such as gadolinium dies or other processes that fail to produce the most efficient number of resolutions to scans and signal to noise ratios. Our technology will solve these issues,” said Dr. Douglas Carpenter, Chief Scientific Officer and Director of Research and Development, QuantumSphere, Inc.